Literature DB >> 30552380

Relieving ER stress to target NASH-driven hepatocellular carcinoma.

Saskia Reibe1, Mark A Febbraio2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30552380     DOI： 10.1038/s41574-018-0145-7

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  2 in total

Review 1.  Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?

Authors:  Mark A Febbraio; Saskia Reibe; Shabnam Shalapour; Geraldine J Ooi; Matthew J Watt; Michael Karin
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

2.  Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.

Authors:  James S V Lally; Sarani Ghoshal; Danielle K DePeralta; Omeed Moaven; Lan Wei; Ricard Masia; Derek J Erstad; Naoto Fujiwara; Vivian Leong; Vanessa P Houde; Alexander E Anagnostopoulos; Alice Wang; Lindsay A Broadfield; Rebecca J Ford; Robert A Foster; Jamie Bates; Hailing Sun; Ting Wang; Henry Liu; Adrian S Ray; Asish K Saha; Jeremy Greenwood; Sathesh Bhat; Geraldine Harriman; Wenyan Miao; Jennifer L Rocnik; William F Westlin; Paola Muti; Theodoros Tsakiridis; H James Harwood; Rosana Kapeller; Yujin Hoshida; Kenneth K Tanabe; Gregory R Steinberg; Bryan C Fuchs
Journal:  Cell Metab       Date:  2018-09-20       Impact factor: 31.373
  2 in total
  8 in total

1.  A new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.

Authors:  Christopher D Green; Cynthia Weigel; Ryan D R Brown; Pierre Bedossa; Mikhail Dozmorov; Arun J Sanyal; Sarah Spiegel
Journal:  FASEB J       Date:  2022-07       Impact factor: 5.834

Review 2.  Current and Future Treatments in the Fight Against Non-Alcoholic Fatty Liver Disease.

Authors:  Benoit Smeuninx; Ebru Boslem; Mark A Febbraio
Journal:  Cancers (Basel)       Date:  2020-06-28       Impact factor: 6.639

3.  Two-Week Isocaloric Time-Restricted Feeding Decreases Liver Inflammation without Significant Weight Loss in Obese Mice with Non-Alcoholic Fatty Liver Disease.

Authors:  Rachel B Wilson; Richard Zhang; Yun Jin Chen; Kia M Peters; Cynthia G Sawyez; Brian G Sutherland; Krisha Patel; John P Kennelly; Kelly-Ann Leonard; René L Jacobs; Rennian Wang; Nica M Borradaile
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

Review 4.  Endoplasmic Reticulum Stress: An Emerging Therapeutic Target for Intervertebral Disc Degeneration.

Authors:  Dong Wang; Xin He; Chao Zheng; Chengzhe Wang; Pandi Peng; Chu Gao; Xiaolong Xu; Yachao Ma; Mei Liu; Liu Yang; Zhuojing Luo
Journal:  Front Cell Dev Biol       Date:  2022-02-01

5.  Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease.

Authors:  Peter P Toth; Gregory G Schwartz; Stephen J Nicholls; Aziz Khan; Michael Szarek; Henry N Ginsberg; Jan O Johansson; Kamyar Kalantar-Zadeh; Ewelina Kulikowski; Ken Lebioda; Norman C W Wong; Michael Sweeney; Kausik K Ray
Journal:  Am J Prev Cardiol       Date:  2022-08-08

6.  RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression.

Authors:  Yanyan Wang; Yun-Ling Tai; Grayson Way; Jing Zeng; Derrick Zhao; Lianyong Su; Xixian Jiang; Kaitlyn G Jackson; Xuan Wang; Emily C Gurley; Jinze Liu; Jinpeng Liu; Weidong Chen; Xiang-Yang Wang; Arun J Sanyal; Phillip B Hylemon; Huiping Zhou
Journal:  Cell Biosci       Date:  2022-10-12       Impact factor: 9.584

7.  LncRNA GOLGA2P10 is induced by PERK/ATF4/CHOP signaling and protects tumor cells from ER stress-induced apoptosis by regulating Bcl-2 family members.

Authors:  Meng-Zhi Wu; Tao Fu; Jin-Xi Chen; Ying-Ying Lin; Jin-E Yang; Shi-Mei Zhuang
Journal:  Cell Death Dis       Date:  2020-04-24       Impact factor: 8.469

Review 8.  Drug Discovery in Liver Disease Using Kinome Profiling.

Authors:  Bingting Yu; Ruslan Mamedov; Gwenny M Fuhler; Maikel P Peppelenbosch
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.